Hippocratic AI Takes on Patient-Facing Healthcare with $141M Raise And Now A Unicorn

The healthcare industry has long struggled with a systemic staffing crisis, one exacerbated by the global demand for care that outpaces available resources. Rising costs, workforce shortages, and an aging population have placed immense strain on the system, with solutions often lagging behind. Yet, AI-driven innovation is emerging to bridge the gap. Leading this charge is Hippocratic AI, a startup developing a large language model (LLM) tailored to healthcare use cases.

In just 18 months, the company has achieved what many could only dream of, combining cutting-edge generative AI with clinician-driven innovation. With its recent $141 million Series B funding round—led by Kleiner Perkins, alongside General Catalyst, Andreessen Horowitz, NVIDIA, and other prominent investors—the startup’s valuation soared to $1.64 billion, earning it coveted "unicorn" status.

Tackling the Workforce Shortage

Hippocratic AI’s mission is clear: address the shortage of nurses, social workers, and other healthcare professionals worldwide. Its generative AI agents, built to handle low-risk, non-diagnostic, patient-facing tasks, provide much-needed support to healthcare organizations. These agents can manage chronic care, post-discharge follow-ups, and even patient education. For example, during recent hurricanes in Florida and wildfires in California, Hippocratic’s AI agents contacted patients to assess care continuity needs.

CEO Munjal Shah, a serial entrepreneur, founded the company alongside physicians, hospital administrators, and AI researchers from prestigious institutions like Stanford, Johns Hopkins, and Google. Their shared vision was to amplify the capacity of healthcare systems by creating AI that not only aids but complements human clinicians.